PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED)

Summary

The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 3 to 6 months of age with bronchiolitis.

Timeline

Start

2003-07

Primary completion

2003-12

Completion

2003-12

Publications

• Background Knorr B, Maganti L, Ramakrishnan R, Tozzi CA, Migoya E, Kearns G. Pharmacokinetics and safety of montelukast in children aged 3 to 6 months. J Clin Pharmacol. 2006 Jun;46(6):620-7. doi: 10.1177/0091270006288324.

Drugs

Indications